Post on 03-Mar-2023
J. Serb. Chem. Soc. 71 (10) 1001–1013 (2006) UDC 546.811–039.7+546.681–039.7:543.4:57–188
JSCS–3494 Original scientific paper
Synthesis, spectroscopic and biological investigations of di-and
triorganotin(IV) derivatives containing germanium: X-ray study
of �Ph3GeCH(n-C3H7)CH2CO2�Sn�CH3�3
MUHAMMAD KALEEM KHOSA1, MUHAMMAD MAZHAR1*, SAQIB ALI1, SARIM
DASTGIR1, MASOOD PARVEZ2 and ABDUL MALIK3
1Department of Chemistry, Quaid-i-Azam University, Islamabad-45320, Pakistan, 2Department of
Chemistry, University of Calgary, 2500 University Drive NW, Calgary, Alberta, Canada T2N 1N4
and 3HEJ Research Institute of Chemistry, International Centre for Chemical Sciences, Univer-
sity of Karachi, Karachi 75270, Pakistan (e-mail: mazhar42pk@yahoo.com)
(Received 25 February, revised 25 April 2005)
Abstract: Bimetallic di- and triorganotin(IV) germanium carboxylates were synthe-sized and characterized by elemental analyses, as well as IR, multinuclear NMR(1H, 13C, 119Sn) spectroscopy and tested for bioactivity. The structure of the repre-
sentative compound, �Ph3GeCH(n-C3H7)CH2CO2�Sn�CH3�3, was determined byX-ray analysis and found to have a distorted trigonal bipyramidal geometry aroundthe tin atom. Some selected compounds were also screened against different micro-bes and showed promising antibacterial and antifungal activity.
Keywords: organotin(IV) carboxylates, organogermanium, spectroscopy, bioacti-vity, X-ray structure.
INTRODUCTION
In the past two decades, organotin carboxylates have received much attention be-
cause of their extensive application in different fields of life science, especially bioci-
dal applications utilizing the antitumour and anticancer activities of such compo-
unds.1–4 The biological importance of organotin compounds has been supported by
structure–activity correlation,5–7 dealing mainly with structural aspects and antitu-
mour activity and also linked with possible tumorigenic activity.8 Organogermanium
compounds form another kind of class that has received considerable attention beca-
use of their potential clinical applications.9 It has been reported that germanium-sub-
stituted organotin carboxylates possess potential activity against certain bacteria.10 In
order to extend the structural chemistry and biological applications of such compo-
unds, a new series of organotin carboxylates has been synthesized. Qualitative structu-
ral characterization of these compounds was based on the C–Sn–C angle. Further, the
1001
doi: 10.2298/JSC0610001K
* Corresponding author.
structure of �3-(triphenylgermyl)hexanoato�trimethyltin(IV) was also confirmed thro-
ugh X-ray crystallography.
EXPERIMENTAL
Chemicals
Substituted cinnamic acid, diorganotin(IV) oxide and triorganotin(IV) chlorides were pur-
chased from Aldrich Chemicals (USA) and were used as received, since their melting points agreed
with the literature values. Germanium dioxide (99.9 % purity) was purchased from the People's Re-
public of China and was used as received. Solvents were dried over sodium benzophenone before
use according to the standard method.11
Instrumentation
Elemental analyses were carried out at the Midwest Micro-Lab Indianapolis, USA. Melting
points were determined with a Mitamura Riken Kogyo (Japan) apparatus and are uncorrected. The
IR spectra were recorded on a Bio-Rad Excalibure FT-IR Model FTS 3000 MX spectrometer, using
the KBr disc technique. The 1H and 13C-NMR spectra were recorded on a Varian Mercury 300 spec-
trometer, operating at 300 and 75.5 MHz, respectively, using deuterated solvents and TMS as the
reference. 119Sn-NMR spectra were obtained on a Bruker 250 ARX spectrometer (Germany) with
TMS as the reference. The crystallogarphic data were collected at 173 K on a Nonius Kappa CCD
diffractometer. The crystals suitable for X-ray diffraction analysis were isolated from a solution in a
mixture of chloroform and acetone over a prolonged period at room temperature.
Synthesis
Germanium substituted diorganotin(IV) derivatives were synthesized by the condensation of
diorganotin oxide and triorganogermyl substituted hexanoic acid in a 1:2 mole ratio in a two-necked
flask fitted with a Dean and Stark apparatus, reflux condenser and magnetic stirrer. The reaction
mixture was refluxed for 10–12 h with continuous azeotropic removal of the formed water. The re-
action mixture was cooled to room temperature, then filtered and the toluene removed under re-
duced pressure. The thick residue was kept at low temperature for a few days and the resulting solid
was recrystallized from a suitable mixture of solvents to yield the product as a white solid.
Triorganotin(IV) derivatives(IV) containing germanium were synthesized by reaction of
triorganotin chloride and triorganogermyl substituted hexanoic acid in a 1:1 mole ratio in the pres-
ence of triethylamine and toluene in a two necked flask fitted with a reflux condenser and magnetic
stirrer. The reaction mixture was refluxed for 8–10 h and then cooled to room temperature. After
cooling, the triethylamine hydrochloride was filtered off. The solvent was evaporated under reduced
pressure and the thick residue kept at room temperature for a few days. The resulting solid was
recrystallized from a suitable mixture of solvents.
Recrystallization
Crystalls suitable for X-ray analysis were grown by dissolving 0.50 g of the compound in a
small quantity of chloroform to form a saturated solution. A few drops of acetone and petroleum
ether were added and the solution allowed to evaporate very slowly at room temperature to yield fine
crystals, which are subsequently washed with acetone.
X-ray crystallography
Intensity data for a colorless crystal (0.16 � 0.16 � 0.10 mm3) were measured at 173(2) K on a
Nonius Kappa CCD diffractometer with graphite monochromatized Mo–K� radiation using � and �
scans to a maximum � value of 27.5°. The data were corrected for Lorentz and polarization effects.
The details of the crystal data and structure refinement are listed in Table I. The structure was solved
by the direct method and refined by full-matrix least squares procedure using SHELXL-97.12 The
1002 KHOSA et al.
non-hydrogen atoms were refined anisotropically. The hydrogen atoms were included at geometri-
cally idealized postions.
TABLE I. Crystal data and structure refinement of compound 6
Empirical formula C27H34GeO2Sn
Formula weight 581.82
Crystal system Monoclinic
Space group P21/c
a/Å 14.148(3)
b/Å 9.235(2)
c/Å 19.684(4)
�/° 99.311(15)
Volume 2538.0(9) Å3
Z 4
Absorption coefficient 2.189 mm-1
�max/° 27.5
Reflections collected 10896
Independent reflections 5771 �R(int)=0.0269�
Max. and min. transmission 0.812 and 0.721
Goodness-of-fit on F2 1.04
Final R indices �I>2sigma(I)� R1 = 0.030, wR2 = 0.065
R indices (all data) R1 = 0.040, wR2 = 0.070
�max(e Å-3) 1.10
RESULTS AND DISCUSSION
3-(Triphenylgermyl)hexanoic acid was synthesized as reported earlier in the
literature.10 Di- and triorganotin(IV) carboxylates containing germanium were re-
spectively prepared in 70–80 % yield by the reaction of diorganotin(IV) oxides and
triorganotin chlorides with 3-(triphenylgermyl)hexanoic acid ligand in a 1:2 and
1:1 mole ratio, respectively,13–15 as given in Eqs. (1) and (2):
R2SnO+2Ph3GeCH(n-C3H7)CH2COOHToluene
� ����
�Ph3GeCH(n-C3H7)CH2CO2�Sn�R�2 + H2O
(1)
R = CH3, C2H5, n-C4H9, n-C8H17, C6H5
R3SnCl + Ph3GeCH(n-C3H7)CH2CO2HEt N3� ���
Ph3GeCH(n-C3H7)CH2CO2Sn[R]3+Et3N·HCl
(2)
R = CH3, n-C4H9, C6H5
Ge ORGANOTIN DERIVATIVES 1003
The compounds are soluble in common organic solvents, such as CHCl3,
CH2Cl2, and DMSO. The physical data are given in Table II.
TABLE II. Physical data of di- and triorganotin(IV) derivatives of the general formula
�(C6H5)3GeCH(n-C3H7)CH2CO2�xSn�R�4-x
Comp.No.
R Molecularformula
M.wt.
M.p.°C
Yield%
Elemental Analysis
C/% H/%
1 CH3 C50H56O4Ge2Sn 985 146–148 71 60.89 5.64
(60.91) (5.68)
2 C2H5 C52H60O4Ge2Sn 1013 145–147 65 61.54 5.90
(61.59) (5.92)
3 n-C4H9 C56H68O4Ge2Sn 1069 152–154 69 62.79 6.34
(62.86) (6.36)
4 n-C8H17 C64H84O4Ge2Sn 1181 138–140 73 64.99 7.12
(65.02) (7.11)
5 C6H5 C60H60O4Ge2Sn 1109 182–184 84 64.89 5.43
(64.92) (5.41)
6 CH3 C27H34O2GeSn 582 140–142 69 55.61 5.81
(55.67) (5.84)
7 C4H9 C36H52O2GeSn 708 188–190 64 60.92 7.33
(61.01) (7.34)
8 C6H5 C42H40O2GeSn 768 175–177 71 65.59 5.21
(65.62) (5.20)
x = 2 for compounds 1–5, 1 for 6–8.
TABLE III. Characteristic IR absorption frequencies in cm-1 of di- and triorganotin(IV) derivatives
with the general formula �(C6H5)3GeCH(n-C3H7)CH2COO�xSn�R�4-x
Comp. v(COO)asym v(COO)sym v v(Ge–C) v(Sn–C) v(Sn–O)
1 1604 1412 192 622 560 469
2 1599 1413 186 621 566 468
3 1606 1410 196 635 563 465
4 1603 1410 193 623 565 467
5 1610 1415 195 631 – 466
6 1601 1427 174 642 557 463
7 1594 1425 169 669 555 467
8 1580 1394 186 667 – 469
x = 2 for compounds 1–5, 1 for 6–8.
Infrared spectroscopy
The infrared spectra of these compounds were recorded in the range of 4000–400
cm–1. The main IR spectral data are listed in Table III. The assignment of Sn–C, Sn–O
1004 KHOSA et al.
and Ge–C are consistent with the values reported in the literature.16 The IR stretching
vibration frequencies of carbonyl groups in organotin(IV) carboxylates are helpful in
elucidating the structures and bonding behavior of the ligand. When the structure of
the complex changes from four to five or higher coordination symmetry, �(COO) asy
shifts to lower and �(COO)sym shift to higher values, which causes a decrease in �.13
The � values for the diorganotin(IV) compounds 1–5 and triorganotin(IV) com-
pounds 6–8 lie in the range of 186 to 196 cm–1 and 174 to 186 cm–1, respectively,
which indicates the bidentate nature of the COO group.17,18 Therefore, distorted octa-
hedral geometry and trigonal bipyramidal geometry are adopted by diorganotin(IV)
and triorganotin(IV) compounds around the tin atom, respectively.
NMR spectroscopy
1H-NMR. The 1H-NMR data of compounds 1–8 are presented in Table IV. All
protons in the compounds were identified by the intensity and multiplicity pattern and
the total number of protons calculated from the integration curve is in agreement with
the expected molecular composition. The proton resonance of the phenyl group of the
triphenyl tin(IV) compounds appeared as multiplets in the range of 6.8–7.2 ppm. The
methylene protons of the di- and tributyltin(IV) derivatives show multiplets in the re-
gion 1.21–2.14 ppm with a well defined triplet at 0.79 and 0.85 ppm, respectively, due
to presence of terminal methyl protons with a 1H–1H coupling constant of about 7.1
and 7.3 Hz.19 The dioctyltin(IV) derivatives exhibited a multiplet in the range of
1.18–1.32 ppm for the methylene protons, with a well defined triplet at 0.85 ppm hav-
ing a 1H–1H coupling constant of about 7.2 Hz. Similarly, for the di- and trimethyl-
tin(IV) derivatives, the methyl protons appeared as a sharp singlet at 0.84 ppm and
0.81 ppm with a well resolved 119Sn–1H coupling constant of 76 Hz and 57 Hz, re-
spectively. The Sn–C–Sn bond angles, 140.32° and 111.56°, calculated from the cou-
pling constant by application of the Lockhart equation, support a five-coordinated ge-
ometry for the diorganotin(IV) and a four-coordinated one for the triorganotin(IV) ger-
manium carboxylates in non-coordinating solvents.20
TABLE IV. 1H-NMR dataa-e for organotin derivatives of the general formula
�(C6H5)3GeCH(n-C3H7)CH2COO�xSn�R�4-x
Comp. CH CH2 n-C3H7 R C6H5Ge
1 3.05 (q, 2H) 2.44–2.58 0.79 (t, 6H, 7.5) 0.84 (s, 6H) 7.45–7.61
3J(6.8) (m, 4H) 1.21–1.75 (m, 8H) 2J�76� (m, 30H)
2 3.02 (q, 2H) 2.39–2.56 0.80 (t, 6H, 7.0) 0.80 (t, 6H, 7.0) 7.29–7.65
3J(7.1) (m, 4H) 1.32–1.72 (m, 8H) 1.16–2.4 (m, 4H) (m, 30H)
3 3.07 (q, 2H) 2.41–2.55 0.79 (t, 6H, 7.1) 0.79 (t, 6H, 7.1) 7.36–7.64
3J(7.1) (m, 4H) 1.29–1.65 (m, 8H) 1.25–2.14 (m, 12H) (m, 30H)
4 3.06 (q, 2H) 2.44–2.60 0.85 (t, 6H, 7.2) 0.85 (t, 6H, 7.2) 7.2–7.6
3J(6.9) (m, 4H) 1.38–1.74 (m, 8H) 1.18–1.32 (m, 28H) (m, 30H)
Ge ORGANOTIN DERIVATIVES 1005
Comp. CH CH2 n-C3H7 R C6H5Ge
5 3.15 (q, 2H) 2.37–2.51 0.89 (t, 6H, 6.9) 7.15–7.55 7.15–7.55
3J(7.6) (m, 4H) 1.36–1.61 (m, 8H) (m, 10H) (m, 30H)
6 2.55 (q, 1H) 2.30–2.45 0.58 (t, 3H, 7.1) 0.25 (s, 9H) 7.0–7.41
3J(7.8) (m, 2H) 1.0–1.5 (m, 4H) 2J�57� (m, 15H)
7 2.78 (q, 1H) 2.38–2.45 0.95 (t, 3H, 6.8) 0.85 (t, 9H, 7.3) 7.35–7.61
3J(7.51) (m, 2H) 1.45–1.85 (m, 4H) 1.21–1.45 (m, 18H) (m, 15H)
8 2.31–2.80 2.46–2.75 0.84 (t, 3H, 6.9) 6.85–7.65 6.85–7.65
(m, 1H) (m, 2H) 1.51–1.70 (m, 4H) (m, 15H) (m, 15H)
ax = 2 for compounds 1–5, 1 for 6–8; bIn CDCl3 at 295 K; cChemical shift in ppm, 3J(1H–1H),nJ�119Sn–1H� in Hz;
dMultiplicity is given as s = singlet, d = doublet, t = triplet, m = multiplet; eR =
CH3 for 1,6, C2H5 for 2, n-C4H9 (3,7), n-C8H17 (4), Ph for 5,8.
13C-NMR. The 13C data of compounds 1–8 are presented in Table V. The as-
signment of methyl, ethyl, n-butyl, n-octyl and aromatic moieties attached to tin
and other unique carbons are based on literature values.15,21 The aromatic carbon
resonances were assigned by comparision of the experimental chemical shifts with
those calculated by the incremental method and literature values.22,23
TABLE V. 13C and 119Sn-NMR dataa–c for organotin derivatives of the general formula
�(C6H5)3GeCH(n-C3H7)CH2COO�xSn�R�4-x
Signal no. 1 2 3 4 5 6 7 8
Ph–Ge a 134.51 133.98 135.26 135.29 135.87 136.61 136.70 136.15
b 133.49 133.89 133.96 133.99 134.25 135.35 135.38 135.22
c 128.53 128.90 128.92 128.96 128.74 128.15 128.17 128.19
d 131.49 131.36 131.07 131.10 131.51 128.77 128.79 128.95
n-C3H7 � 27.91 27.72 27.72 27.75 27.67 23.57 23.58 23.62
� 24.01 23.83 23.79 23.84 23.49 22.23 22.29 22.31
� 13.92 13.82 13.78 14.13 13.91 14.22 14.32 14.27
CH 33.44 33.44 33.43 33.46 33.44 34.56 34.65 34.51
CH2 38.53 38.53 38.52 38.55 38.49 37.14 37.22 37.34
COO 177.69 177.57 177.53 177.55 177.51 179.48 179.48 179.67
Sn–C 1 4.5 13.82 23.79 27.75 134.67 –2.54 16.39 135.30
1J�649� 1J�585� 1J�592� 1J�360� 1J�355�
2 – 8.65 27.72 29.71 133.14 – 27.90 134.51
2J�20� 2J�19� 2J�21�
3 – – 27.51 33.46 129.21 – 27.11 128.84
4 – – 13.78 31.9 131.47 – 13.72 128.79
5 – – – 31.8 – – – –
1006 KHOSA et al.
TABLE IV. Continued
Signal no. 1 2 3 4 5 6 7 8
6 – – – 23.84 – – – –
7 – – – 22.85 – – – –
8 – – – 13.82 – – – –
119Sn –125.9 –165.8 –168.7 –149.4 –179.6 129.1 120.5 107.2
ax = 2 for compounds 1–5, 1 for 6–8; b In CDCl 3 at 295 K; c Chemical shift in ppm.nJ�119Sn–1H� in Hz. n-C3H7 = �CH2– CH2–�CH3, Sn–CH3, Sn–1CH2–2CH3,
Sn–1CH2–2CH2–3CH2–4CH3, Sn–1CH2–2CH2–3CH2–4CH2–5CH2–6CH2–7CH2–8CH3
In the di- and trimethyltin(IV) compounds, the methyl carbon directly attached
to tin gave signals at 4.5 and –2.54 ppm with coupling constants 1J�119Sn–13C� of
649 and 360 Hz, respectively. In the di- and tributyltin(IV) compounds, the carbon
atom directly attached to tin was found at 23.79 and 16.79 ppm with coupling con-
stants 1J[119Sn–13C] of 585 and 355 Hz respectively. The position of the car-
boxylate carbon in all the synthesized compounds moved slightly to lower field as
compared with the substituted germyl hexanoic acid and lay in the range of
177–182 ppm indicating a weak participation of the carboxylic group in the coor-
dination of tin(IV).24,25 The values of nJ�119Sn–13C� fell in the range of 585 to 649
Hz for the diorganotin and 355 to 360 Hz for the triorganotin compounds, which
reflects a five to four-coordinated environment around the tin atom of the corre-
sponding compounds in non-coordinated solvents.26,27
119Sn-NMR. The 119Sn-NMR data for the synthesized compounds are listed in
Table V. 119Sn-NMR spectra give a sharp singlet, indicating the formation of a single
species. The 119Sn chemical shift moves to a lower frequency with increasing coordi-
nation number. The range was between + 200 to – 60 ppm for the four-coordinated
compounds and from –90 to –330 ppm for the five-coordinating system.10 Since
diorganotin(IV) compounds have � values between –125.9 to –179.6 ppm, this would
indicate that the compounds are five coordinated while in triorganotin(IV) com-
pounds, � values between 107.2 to 129.1 ppm show that the compounds are four-coor-
dinated. These results are consistent with the 1H and 13C-NMR results.
Mass spectrometry
The 80 eV monoisotopic mass spectral fragmentation patterns of the investigated
compounds 4,7 are cited in Table VI. The fragmentation pattern mainly depends on the
structure of the compounds and the properties of the carbonyl group.28 Diorganotin
compounds have a more complex fragmentation pattern as compared to triorganotin(IV)
carboxylates. The primary fragmentation of the diorganotin(IV) compounds is due to the
loss of the germyl acid unit, while in the triorganotin(IV) carboxylates, the primary frag-
mentation is due to loss of R. The rest of fragmentation follows the same pattern as re-
ported earlier.29 However, �R2Sn�, �RSn� and �R� group fragments are commonly ob-
served in both di- and triorganotin(IV) carboxylates.
Ge ORGANOTIN DERIVATIVES 1007
TABLE V. Continued
TA
BL
EV
I.F
rag
men
tio
ns
ob
serv
edfo
rco
mp
ou
nd
s4
and
7
m/z
Co
mp
ou
nd
4fr
agm
ents
Inte
nsi
tym
/zC
om
po
un
d7
frag
men
tsIn
ten
sity
11
84
�((C
6H
5) 3
GeC
H(n
-C3H
7)C
H2C
O2) 2
Sn
(n-C
8H
17) 2
�+n
.o7
10
�((C
6H
5) 3
GeC
H(n
-C
3H
7)C
H2C
O2)S
n(n
-C
4H
9) 3
�+1
.06
76
5��
(C
6H
5) 3
GeC
H(C
3H
7)C
H2C
OO
Sn
(C8H
17) 2
�+3
.21
65
3�(
(C
6H
5) 3
GeC
H(C
3H
7)C
H2C
OO
)Sn
(C4
H9) 2
�+6
5.4
8
45
9�C
H(C
3H
7)C
H2C
OO
Sn
(C8H
17)–
H�+
10
04
19
�(C
6H
5) 3
GeC
H(C
3H
7)C
H2C
OO
�+2
0.8
1
41
9�(
C6H
5) 3
GeC
H(C
H2C
H2C
H3)C
H2C
OO
�+3
0.2
14
05
�CH
3(C
H2) 3
CO
2S
n(C
4H
9)�
+1
6.4
37
6�(
C6H
5) 3
GeC
HC
H2C
O2�+
42
.80
34
9�C
H2C
O2S
n(C
4H
9) 3
�+2
5.6
34
6�S
n(C
8H
17) 2
�+1
8.3
23
48
[C
H3(C
H2) 3
CO
OS
n(C
4H
9)�
+1
0.9
2
30
5�(
C6H
5) 3
Ge�+
83
.20
30
5��
C6H
5) 3
Ge�+
10
0
29
9�(
C6H
5) 2
GeC
HC
H2C
O2�+
46
.74
29
2�C
H2C
O2S
n(C
4H
9) 2
�+6
.43
23
3�S
n(C
8H
17)�
+5
0.0
12
91
�Sn
(C
4H
9) 3
�+8
.76
22
8�(
C6H
5) 2
Ge�+
27
.52
23
4�S
n(C
4H
9) 2
�+2
0.5
4
15
1�(
C6H
5)G
e�+
28
.16
22
8�(
C6H
5) 2
Ge�+
25
.31
12
1�S
nH
�+9
.60
22
7�(
C6H
5) 2
Ge–
H�+
19
.26
11
3�n
-C8H
17�+
15
.36
17
7�S
n(C
4H
9)�
+4
1.0
1
74
�Ge�+
3.2
71
51
�(C
6H
5)G
e�+
16
.05
71
�CH
CH
2C
O2�+
80
.01
21
�Sn
H�+
14
.12
74
�Ge�+
8.7
6
Crystal Structure of [(C6H5)3GeCH(n-C3H7)CH2COO]Sn(CH3)3
The crystal structure of [(C6H5)3GeCH(n-C3H7)CH2COO]Sn(CH3)3 is depicted
in Fig. 1. Selected bond lengths and bond angles are listed in Table VII. The four-coor-
dinated germanium atom has a slightly distorted tetrahedral geometry with the mean of
the C–Ge–C bond angles being 108.31(11)°. The Ge–Csp3 bond is significantly longer,
1.988(3) Å, than the Ge–Caromatic distances, which are identical within experimental
error with a mean value of 1.956(3) Å. The tin atom has a distorted trans-R3SnO2
trigonal bipyramidal geometry with the methyl groups in the equatorial plane and the
oxygen from two asymmetric units of the carboxylate group occupying the axial posi-
tion, whereby a polymeric structure is developed. The tin atom is 0.098 Å out of plane
towards the more strongly bound oxygen atom. The Sn–C distances lie in the range of
2.117(3) to 2.122(3) Å and are in agreement with the corresponding literature values.30
The C–O bonds within the carboxyl group also have different lengths. The longer
C(4)–O(1) bond, 1.289(3) Å, and the shorter Sn(1)–O(1) bond, 2.136(18) Å, share the
same oxygen atom and vice versa. This could mean that one of the carboxyl oxygen at-
oms forms a covalent bond with the tin atom, while the other carboxyl oxygen atom
(double bonded) is coordinated to tin with a longer Sn–O distance because the C–O
bond retains some of its double bond character.
Biological studies
The in vitro biological activities of the selected compounds were determined
against various bacteria and fungi by the agar well diffusion and agar well dilution
protocols.31,32 The results are given in Tables VIII and IX.
The antibacterial activity was studied against six different types of bacteria, E.
coli, B. subtilis, S. flexinari, S. aureus, P. aeruginosa and S. typhi, relative to reference
drug, imipenum. The activities of the synthesized compounds were compared on the
basis of the substituent group R. The screening tests show that the n-butyltin(IV) and
Ge ORGANOTIN DERIVATIVES 1009
Fig. 1. X-ray structure of [(C6H5)3GeCH(n-C3H7)CH2COO)]Sn(CH3)3.
n-octyltin(IV) carboxylates are the most potent against the tested bacteria. However,
all the compounds show good activity against E. coli and S. typhi.
TABLE VII. Selected bond lengths/Å and bond angles/° for compound 6
Bond Lengths
Sn(1)–C(3) 2.117(3) O(1)–C(4) 1.289(3)
Sn(1)–C(1) 2.118(3) O(2)–C(4) 1.232(3)
Sn(1)–C(2) 2.122(3) C(4)–C(5) 1.524(4)
Sn(1)–O(1) 2.136(18) C(5)–C(6) 1.536(4)
Sn(1)–O(2)#1 2.645(2) C(6)–C(7) 1.538(4)
Ge(1)–C(22) 1.952(3) C(7)–C(8) 1.502(5)
Ge(1)–C(16) 1.955(3) C(8)–C(9) 1.551(5)
Ge(1)–C(10) 1.962(3) C(10)–C(15) 1.338(4)
Ge(1)–C(6) 1.988(3) C(10)–C(11) 1.390(4)
Bond Angles
C(3)–Sn(1)–C(1) 127.14(14) C(4)–O(1)–Sn(1) 116.32(17)
C(3)–Sn(1)–C(2) 114.25(14) O(1)–Sn(1)–O(2)#1 178.31(7)
C(1)–Sn(1)–C(2) 114.96(14) C(3)–Sn(1)–O(2)#1 80.63(11)
C(3)–Sn(1)–O(1) 98.05(11) C(1)–Sn(1)–O(2)#1 83.13(10)
C(1)–Sn(1)–O(1) 98.52(10) C(2)–Sn(1)–O(2)#1 87.79(10)
C(2)–Sn(1)–O(1) 91.82(10) O(2)–C(4)–C(5) 121.4(2)
C(22)–Ge(1)–C(16) 107.36(11) O(2)–C(4)–O(1) 123.0(2)
C(22)–Ge(1)–C(10) 110.42(11) O(1)–C(4)–C(5) 115.6(2)
C(16)–Ge(1)–C(10) 106.66(11) C(5)–C(6)–Ge(1) 112.82(18)
C(22)–Ge(1)–C(6) 107.83(11) C(7)–C(6)–Ge(1) 115.86(18)
C(16)–Ge(1)–C(6) 117.27(11) C(15)–C(10)–Ge(1) 121.61(2)
TABLE VIII. Antibacterial activity dataa-c of organotin derivatives (in vitro)
Name ofbacteria
Zone of inhibition of sample/mm Zone ofinhibition of
std. drug/mm1 2 3 4 5 6 7 8
Escherichia coli 14 18 25 29 12 14 28 19 30
Bacillus subtilis 10 16 30 28 10 27 29 15 31
Shigella flexenari – – – – – – – – 33
Staphylococcus
aureus
12 14 23 39 10 22 40 14 43
Pseudomonas
aeruginosa
10 15 14 23 5 12 24 17 25
Salmonella typhi 36 38 39 35 15 24 40 23 41
aConcentration of sample = 3 mg/mL; bConcentration of standard drug (imipenum) = 10 �g/disc;
c(–) = No activity
1010 KHOSA et al.
TABLE IX. Antifungal activity dataa-c of organotin derivatives (in vitro)
Name offungus
Inhibition of samples Std. drug
MIC �g/mL
% Inhibition ofstd. drug/mm
1 2 3 4 5 6 7 8
Trichophyton
longifusus
65 50 40 68 30 30 70 56 Miconazole 70
Candida albicans 40 40 55 101 60 60 108 78 " 110
Aspergillus flavus 20 – – – – – – 35 Amphotericin B 20
Microsporum
canis
35 20 45 87 30 30 90 55 Miconazole 98
Fusarium solani 60 60 30 65 30 30 63 49 " 73
Candida
glaberata
105 99 95 86 48 30 108 78 " 110
aConcentration of sample = 400 �g/mL of DMSO;bIncubation temperature (period) = 27 ± 1°C (7
days); c(–) = No activity
The agar tube dilution protocol was used to screen the activity of compounds
against different types of fungi, T. longifusus, C. albicans, A. flavus, M. canis, F.
solani and C. glaberata. Earlier reports show that tributyltin(IV) and triphenyl-
tin(IV) compounds show higher antifungal activity.33 The antifungal screening re-
sults of the synthesized compounds are in good agreement with the literature and
show good activity against the tested fungi.
The toxicity of these compounds, particularly dioctyltin(IV), was decreased
by the incorporation of germanium.15 The toxicity of the synthesized compounds
was measured by the brine shrimp (Artemia salina) method and their lethal doses
(LD50) are given in Table X. It can be seen that the toxicity of the organotin com-
pounds mainly depends on the nature of the organic group,34 the highest toxicity
being shown by those compounds having three tin carbon (Sn–C) bonds.
TABLE X. Cytotoxicity dataa-c of organotin(IV)
Comp. No. LD50/�g mL-1
1 502.09
2 501.18
3 508.01
4 305.38
5 499.01
6 25.64
7 59.98
8 12.15
bEtoposide 7.46
aOrganism = Artemia salina (brine shrimp); bReference drug; cLD50 = Lethal dose at which 50% of
the organism die
Ge ORGANOTIN DERIVATIVES 1011
Supplementary data
Crystallographic data for the compound 6 have been deposited with the Cam-
bridge Crystallographic Data Centre, as CCDC Number: 261767. Copies of the data
can be obtained on request to CCDC, 12 Union Road, Cambridge CB21, EZ, UK.
E-mail: deposited@ccdc.cam.ac.uk or http://www.ccdc.cam.ac.uk.
Acknowledgements: We thank the Higher Education Commission, Islamabad, Pakistan for fi-nancial support. (Grant No. 20-9/Acad-R/2003).
I Z V O D
SINTEZA, SPEKTROSKOPSKO I BIOLO[KO ISPITIVAWE DI- I
TRIORGANOKALAJNIH(IV) DERIVATA KOJI SADR@E GERMANIJUM:
KRISTALOGRAFSKO PROU^AVAWE �Ph3GeCH(n-C3H7)CH2CO2�Sn�CH3�3
MUHAMMAD KALEEM KHOSA1, MUHAMMAD MAZHAR1, SAQIB ALI1, SARIM DASTGIR1, MASOOD PARVEZ2
i ABDUL MALIK3
1Department of Chemistry, Quaid-i-Azam University, Islamabad-45320, Pakistan, 2
Department of Chemistry, University of
Calgary, 2500 University Drive, NW, Calgary, Alberta, Canada T2N 1N4 i3
HEJ Research Institute of Chemistry, Interna-
tional Centre for Chemical Sciences, University of Karachi, Karachi 75270, Pakistan
Sintetizovani su bimetalni di- i triorganokalajni(IV) germanijumski karbo-
ksilati, okarakterisani elementalnom analizom, IR i multinuklearnom NMR (1H,
13C, 119Sn) spektroskopijom i testirani na biolo{ku aktivnost. Struktura reprezen-
tativnog jediwewa, �Ph3GeCH(n-C3H7)CH2CO2�Sn�CH3��, odre|ena je difrakcijom X-zra-
ka. Utvr|ena je distorgovana trigonalna bipiramidalna geometrija oko atoma kalaja.
Neka odabrana jediwewa su ispitivana sa aspekta biolo{ke aktivnosti prema razli-
~itim mikrobima i pokazana je wihova antibakterijska i antigqivi~na aktivnost.
(Primqeno 25. februara, revidirano 25. aprila 2005)
REFERENCES
1. A. G. Davies, P. J. Smith, Comprehensive Organometallic Chemistry, Vol. 2, G. Wilknson, F. G.Stone, E. W. Able, Eds., Pergamon, Oxford, 1982, p. 519
2. G. Tagliavini, J. Organomet. Chem. 473 (1992) 153. A. K. Brimah, E. Siebel, R. D. Fischer, N. A. Davies, D. C. Apperlay, R. K. Haris, J. Organomet.
Chem. 475 (1994) 854. M. Nath, S. Pokharia, X. Song, G. Eng, M. Gielen, M. Kemmer, M. Biesemans, R. Willem, D.
deVos, J. Organomet. Chem. 71 (2003) 3055. A. K. Sexena, F. Huber, Coord. Chem. Rev. 95 (1989) 1096. S. P. Gupta, Chem. Rev. 94 (1994) 15077. M. Gielen, Tin-based Antitumour Drugs, NATO-ASI series, H 37, Springer, Berlin, 19908. C. E. Holloway, M. Melnik, Main Group Met. Chem. 23 (2000) 5559. K. Asai, Miracle Cure; Organic Germanium, Japan publications, New York, 1980
10. M. A. Choudhary, M. Mazhar, S. Ali, X. Song, G. Eng, Metal Based Drugs 8 (2002) 27511. W. L. F. Armarego, D. D. Perrin, Purification of Laboratory Chemicals, 4th Ed.; Pergamon, Ox-
ford, 199712. G. M. Sheldrick, SHELXL-97, University of Göttingen, Germany, 1997
13. F. Ahmed, S. Ali, M. Parvez, A. Munir, M. Mazhar, K. M. Khan, T. A. Shah, Heteroatom Chem.
13 (2002) 63814. S. Ali, F. Ahmad, M. Mazhar, A. Munir, M. T. Masood, Synth. React. Inorg. Met.-Org. Chem. 32
(2001) 357
1012 KHOSA et al.
15. Imtiaz-ud-Din, M. Mazhar, K. M. Khan, M. F. Mahon, K. C. Molloy, J. Organomet. Chem. 689
(2004) 89916. X. Song, Z. Yang, Q. Xie, L. Jiang, J. Organomet. Chem. 566 (1998) 103
17. G. K. Sandhu, R. Hunda, E. R. T. Tiekink, J. Organomet. Chem. 430 (1992) 15
18. G. K. Sandhu, N. S. Boparoy, Synth. React. Inorg. Met.-Org. Chem. 20 (1990) 975
19. M. H. Bhatti, S. Ali, H. Masood, M. Mazhar, S. I. Qureshi, Synth. React. Inorg. Met.-Org. Chem.
30 (2000) 1715
20. T. P. Lockhart, W. F. Manders, E. M. Holt, J. Am. Chem. Soc. 108 (1986) 6611
21. S. Ahmed, S. Ali, F. Ahmed, M. H. Bhatti, A. Badshah, M. Mazhar, K. M. Khan, Synth. React.
Inorg. Met.-Org. Chem. 32 (2002) 1521
22. H. O. Kalinowski, S. Berger, S. Brown, 13C-NMR Spektroskopie, Thieme Verlag, Stuttgart, Ger-
many, 1984
23. X. Q. Song, Q. L. Xie, X. N. Fang, Heteroatom Chem. 13 (2002) 592
24. M. Danish, H. G. Alt, A. Badshah, S. Ali, M. Mazhar, N. Islam, J. Organomet. Chem. 486 (1995)
51
25. M. Danish, S. Ali, M. Mazhar, A. Badshah, Main Group. Met. Chem. 19 (1996) 121
26. E. Willem, A. Bouhdid, B. Mahieu, L. Ghys, M. Biesemans, E. R. T. Tiekink, D. de Vos, M.
Gielen, J. Organomet. Chem. 531 (1997) 151
27. T. A. A. Allaf, J. Organomet. Chem. 306 (1986) 337
28. Q. Xie, Z. Yang, L. Jiang, Main Group Met. Chem. 19 (1996) 509
29. M. Danish, S. Ali, M. Mazhar, Polyhedron 14 (1995) 3115
30. M. Parvez, M. H. Bhatti, S. Ali, M. Mazhar, S. I. Qureshi, Acta Crystallogr., Sect. C: Cryst.
Struct. Commun., C 56 (2000) 327
31. S. S. Shaukat, N. A. Khan, F. Ahmed, Pak. J. Bot. 12 (1980) 97
32. A. Rahman, M. I. Choudhary, W. J. Thomsen, Bioassay Techniques for Drug Development; Har-
vard Academic Press, Amsterdam, 2001, p. 14
33. M. R. Krigman, A. P. Silverman, Neurotoxicology 5 (1984) 129
34. J. M. Barnes, H. B. Stoner, Br. J. Ind. Med. 15 (1985) 15.
Ge ORGANOTIN DERIVATIVES 1013